Expert Analysis

Cannabis, Psychedelics Boom Raises IP Hurdles

Recent data regarding patent filing activity and litigation in the cannabis and psychedelics markets indicates tha... (more story)

5 Practice Tips After DOJ's Healthcare Fraud Declination

In light of the U.S. Department of Justice's decision to not prosecute Campus Eye Management under the agency's ne... (more story)

FDA Closeout Letter Suggests Relaxing Stance On Wearables

The U.S. Food and Drug Administration's recent decision not to pursue enforcement action against Whoop's wearable ... (more story)

Deals & Corporate Governance More

Fed. Circ. Agrees Globus Didn't Infringe Spinal Surgery IP

The Federal Circuit on Friday upheld a Pennsylvania federal judge's decisions clearing Globus Medical Inc. of infringing Moskowitz Family LLC spinal surgery tool patents, agreeing that language used in the pat... (more story)

Biosimilars Boast Big Savings But Face IP Risks, Report Says

There are no biosimilar drugs in development for 90% of biologic products set to lose their patent exclusivity by 2034, according to a report released Thursday by the Association for Accessible Medicines, whic... (more story)

FTC Chucks Biden-Era Health App Breach Notification Policy

The Federal Trade Commission, as part of its regulatory streamlining, has rescinded a Biden-era policy requiring health applications and smart devices that collect information to warn users when their medical ... (more story)

Biogen Must Face Pharmacies' MS Drug Monopoly Suit

An Illinois federal judge on Tuesday refused to dismiss Walgreens and Kroger's lawsuit accusing Biogen Inc. of illegally stifling competition for its multiple sclerosis drug Tecfidera, saying they've made suff... (more story)

Justices' Hikma Reasoning May Extend Well Beyond Pharma

The active steps framework announced by the U.S. Supreme Court in its Hikma v. Amarin decision, finding that Amarin failed to plausibly allege inducement of infringement, has the potential to reshape how court... (more story)

Prepping Health Businesses For Sale In A Data-Driven Market

In a thinner market for healthcare transactions, with both regulators and buyers using artificial intelligence to inspect data in great detail, the margin for error in sellers' financials and legal diligence h... (more story)

Digital Health & Technology More

11th Circ. Urged To Undo Trial Loss For Hospital Ratings Org

A Florida federal court order requiring hospital ratings nonprofit Leapfrog to revoke poor safety grades it issued to five hospitals owned by Tenet Healthcare Corp. violated the First Amendment, Leapfrog told ... (more story)

Apple Watch Ban In Masimo ITC Patent Case Hits High Court

Apple Inc. has told the U.S. Supreme Court that the Federal Circuit improperly "lowered the bar" for meeting the U.S. International Trade Commission's domestic industry requirement in patent disputes, by affir... (more story)

Squires Grants 10 Patent Reviews, Rejects None

U.S. Patent and Trademark Office Director John Squires has instituted 10 more Patent Trial and Appeal Board petitions, largely in the pharmaceutical space.

Judge Won't Touch Verdict In Blood Collection Patent Case

A Delaware federal judge has denied a bid from medical equipment maker Kurin for a new trial after a jury found it owed Magnolia Medical $1.6 million for infringement of three patents covering blood culture co... (more story)

NJ Tech Chief Seeks To Avoid TikTok Depo In AG's Fraud Suit

New Jersey Chief Technology Officer Kevin Dehmer has asked a state court judge to block TikTok from deposing him in the attorney general's consumer fraud lawsuit, arguing that he has no firsthand knowledge of ... (more story)

Calif. Judge Hands Eli Lilly Mixed Bag In Compound Drug Suit

Eli Lilly failed to plausibly allege that a physician group and pharmacy conspired to falsely advertise compounded versions of its diabetes and weight loss drugs, but can continue with allegations they conspir... (more story)

Policy & Compliance More

Dems Demand Info From DeSantis On $10M Fraud

Democratic federal lawmakers sent a letter to Florida Republican Gov. Ron DeSantis seeking more information on $10 million in misappropriated settlement funds, demanding answers to why the money was diverted t... (more story)

Tylenol Maker Seeks 2nd Circ. Relook In Autism, ADHD Suits

Tylenol maker Kenvue and several retailers have urged the Second Circuit to revisit its decision overturning a district court's exclusion of expert testimony for plaintiffs who claim prenatal exposure to the o... (more story)

CVS Renews Bid To Escape Investors' AI Use Suit

CVS Health Corp. wants a second shot at dismissing a lawsuit accusing it of inflating its revenues through the use of artificial intelligence, arguing investors haven't shown it was using the technology to den... (more story)

11th Circ. Ruling Won't Prevent Qui Tam Constitutional Tests

The Eleventh Circuit's holding that the False Claims Act's provisions letting private individuals sue on the federal government's behalf pass muster under the U.S. Constitution may do little to halt the growin... (more story)

3 Takeaways From EBSA's New Health Parity Guidance Docs

The U.S. Department of Labor's recent guidance on how to comply with federal laws requiring parity in health plan coverage between behavioral and physical healthcare provides critical new details on the agency... (more story)

Conduent Settles Claims Over Data Breach That Affected 44M

Conduent Business Services LLC has reached a deal to resolve plaintiffs' claims in a proposed class action alleging it failed to adequately protect sensitive personal and health information of more than 44 mil... (more story)